Can you use weight loss injections short term?

Both Mounjaro and Wegovy are licensed for continuous use alongside diet and activity changes, not as short courses — but short-term use is clinically possible in specific circumstances.
Trial data shows most people regain a significant proportion of lost weight within a year of stopping, because the medicines suppress appetite rather than permanently alter the underlying biology.
Duration is a clinical decision: a prescriber considers your BMI, any weight-related conditions, your progress, and whether continuing treatment outweighs stopping.
If you're thinking about a time-limited course, the most productive conversation is with a GPhC-registered prescriber who can weigh up the evidence alongside your individual situation.

Using weight loss injections short term is possible, but whether it makes clinical sense depends on your goals, your starting point, and what happens when you stop. Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are licensed for ongoing weight management rather than a fixed course, and clinical evidence consistently shows that weight returns for most people after stopping — a fact that belongs at the centre of any honest answer to this question. These are prescription-only medicines, assessed individually by a prescriber; what's right for you depends on the whole clinical picture.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The short-term question: what the evidence and licensing actually say

The decision you're probably weighing up

Most people asking this question fall into one of two camps. Either they want to lose a defined amount of weight for a specific reason (a health milestone, preparation for surgery, a window before trying to conceive) and then stop. Or they're already on treatment, it's working, and they're wondering whether they can step off once they've reached their target.

Both are legitimate things to think about. The tension is that these medicines work by actively suppressing appetite signals; they don't retrain the body to maintain a lower weight permanently. Once the drug clears your system, those signals return. That's not a flaw in the medicine, it's how the biology works, and it's why most clinical guidance treats this as a long-term intervention rather than a finite course.

A question our prescribers hear most weeks is some version of: "I just want to use it to get started." That instinct isn't wrong. Some people do use a shorter course as a bridge, to reduce weight ahead of joint surgery, for example, or to bring blood pressure down. Whether that's appropriate is a clinical call, made case by case, not a general rule.

Before reaching a decision, it's worth reading about how GLP-1 weight loss injections work in practice, the mechanism matters for understanding why the short-term question is genuinely complicated.

What happens when you stop, and why it shapes the decision

The most relevant piece of evidence here comes from the STEP 1 extension study for semaglutide. Participants who stopped treatment after 68 weeks regained on average about two-thirds of their lost weight within a year. The original STEP 1 trial, published in the New England Journal of Medicine, showed around 15% average weight loss at the maintenance dose, so the regain after stopping is substantial for most people.

Tirzepatide data tells a similar story. Weight loss during treatment is real and clinically meaningful; weight regain after stopping is also real and, for many people, significant. This is why stopping weight loss injections deserves its own careful thought rather than a quick decision.

None of this means short-term use is always wrong. If someone loses 12% of their body weight over six months, reduces their blood pressure meaningfully, and then stops with a solid lifestyle plan in place, that may still represent a net health gain, even if some weight returns. The question is whether the clinical benefit of a time-limited course justifies starting at all, or whether it sets up a frustrating cycle. That's not a question with a universal answer.

It's also worth knowing that the dose titration schedule (starting low and stepping up) takes around four to five months to reach a full maintenance dose. A very short course may mean most of it is spent at doses that haven't yet reached therapeutic effect.

What the licensing says about duration

Neither Mounjaro nor Wegovy carries a maximum treatment duration in its UK licence for weight management. This puts them in a different category from Wegovy as recommended by NICE under TA875, which does specify a two-year cap within specialist NHS services. That restriction applies to NHS prescribing within the NICE recommendation framework, not to private prescriptions, which follow the medicine's licensed indication and the prescriber's clinical judgement.

For NHS patients accessing Wegovy through a specialist weight management service, the two-year limit is a real consideration. For people using either medicine privately through a regulated pharmacy, duration is determined by ongoing clinical review rather than a fixed rule. At nume, every repeat order goes through a fresh clinical assessment, there's no auto-renewal, and no prescription is extended without a prescriber looking at your progress again. You can read about what that process involves on the eligibility criteria for weight loss injections page.

If you're considering the long-term picture, the evidence and practical questions around using weight loss injections over a longer period are worth reviewing before you make any decision about when to stop.

Thinking through your options

Short-term use (broadly understood as anything under six months) is unlikely to get you to the licensed maintenance dose, let alone keep you there long enough to see the outcomes the clinical trials measured. That's a practical consideration, not a moral judgement.

If your situation has a defined clinical end-point (surgery, pregnancy planning, a specific comorbidity target), that changes the calculus. Your prescriber can set treatment goals tied to those milestones rather than open-ended weight loss. The guidance on how long you can use weight loss injections covers the different scenarios in more detail.

What matters most is that the decision is made with full information. The NHS notes that GLP-1 medicines are not assessed for quick or cosmetic weight loss, and the MHRA has been clear that these are serious medicines requiring proper clinical oversight. Pricing and cost context for private treatment are covered on the weight loss injection cost page if that's part of your thinking.

If you want a prescriber to look at your specific situation, check your eligibility with our clinical team, consultations are free, and a real prescriber reviews every case the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions